nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—SLC22A1—hematologic cancer	0.352	0.775	CbGaD
Vecuronium—ABCB1—hematologic cancer	0.102	0.225	CbGaD
Vecuronium—SLC22A1—Cytarabine—hematologic cancer	0.0522	0.143	CbGbCtD
Vecuronium—SLC22A1—Cladribine—hematologic cancer	0.0493	0.135	CbGbCtD
Vecuronium—SLC22A1—Imatinib—hematologic cancer	0.0453	0.124	CbGbCtD
Vecuronium—ABCB1—Lenalidomide—hematologic cancer	0.0309	0.0844	CbGbCtD
Vecuronium—ABCB1—Daunorubicin—hematologic cancer	0.0181	0.0495	CbGbCtD
Vecuronium—ABCB1—Alitretinoin—hematologic cancer	0.0178	0.0485	CbGbCtD
Vecuronium—ABCB1—Imatinib—hematologic cancer	0.0139	0.0379	CbGbCtD
Vecuronium—ABCB1—Nilotinib—hematologic cancer	0.0126	0.0345	CbGbCtD
Vecuronium—ABCB1—Vinorelbine—hematologic cancer	0.0125	0.0342	CbGbCtD
Vecuronium—ABCB1—Dasatinib—hematologic cancer	0.0112	0.0305	CbGbCtD
Vecuronium—ABCB1—Mitoxantrone—hematologic cancer	0.011	0.0301	CbGbCtD
Vecuronium—ABCB1—Betamethasone—hematologic cancer	0.00982	0.0268	CbGbCtD
Vecuronium—ABCB1—Gemcitabine—hematologic cancer	0.00973	0.0266	CbGbCtD
Vecuronium—ABCB1—Prednisolone—hematologic cancer	0.00969	0.0265	CbGbCtD
Vecuronium—ABCB1—Prednisone—hematologic cancer	0.00915	0.025	CbGbCtD
Vecuronium—ABCB1—Irinotecan—hematologic cancer	0.00867	0.0237	CbGbCtD
Vecuronium—ABCB1—Vinblastine—hematologic cancer	0.00771	0.0211	CbGbCtD
Vecuronium—ABCB1—Vincristine—hematologic cancer	0.00758	0.0207	CbGbCtD
Vecuronium—ABCB1—Cisplatin—hematologic cancer	0.00707	0.0193	CbGbCtD
Vecuronium—ABCB1—Etoposide—hematologic cancer	0.00695	0.019	CbGbCtD
Vecuronium—ABCB1—Dexamethasone—hematologic cancer	0.00571	0.0156	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—hematologic cancer	0.00474	0.0129	CbGbCtD
Vecuronium—ABCB1—Methotrexate—hematologic cancer	0.00459	0.0125	CbGbCtD
Vecuronium—Rocuronium—SLC22A1—hematologic cancer	0.0013	0.512	CrCbGaD
Vecuronium—Pancuronium—SLC22A1—hematologic cancer	0.00124	0.488	CrCbGaD
Vecuronium—CHRNA1—hematopoietic system—hematologic cancer	0.000229	0.221	CbGeAlD
Vecuronium—CHRND—lung—hematologic cancer	0.000159	0.154	CbGeAlD
Vecuronium—Nervous system disorder—Thiotepa—hematologic cancer	0.000147	0.000911	CcSEcCtD
Vecuronium—Hypotension—Vinorelbine—hematologic cancer	0.000147	0.000909	CcSEcCtD
Vecuronium—Tachycardia—Thiotepa—hematologic cancer	0.000146	0.000907	CcSEcCtD
Vecuronium—Skin disorder—Thiotepa—hematologic cancer	0.000146	0.000903	CcSEcCtD
Vecuronium—Hypersensitivity—Cladribine—hematologic cancer	0.000145	0.0009	CcSEcCtD
Vecuronium—Rash—Busulfan—hematologic cancer	0.000145	0.000897	CcSEcCtD
Vecuronium—Dermatitis—Busulfan—hematologic cancer	0.000145	0.000896	CcSEcCtD
Vecuronium—Erythema—Cisplatin—hematologic cancer	0.000144	0.000893	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—hematologic cancer	0.000143	0.000886	CcSEcCtD
Vecuronium—Urticaria—Melphalan—hematologic cancer	0.000143	0.000885	CcSEcCtD
Vecuronium—Shock—Thalidomide—hematologic cancer	0.000143	0.000884	CcSEcCtD
Vecuronium—Nervous system disorder—Thalidomide—hematologic cancer	0.000142	0.000882	CcSEcCtD
Vecuronium—Tachycardia—Thalidomide—hematologic cancer	0.000142	0.000877	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—hematologic cancer	0.000141	0.000876	CcSEcCtD
Vecuronium—Skin disorder—Thalidomide—hematologic cancer	0.000141	0.000873	CcSEcCtD
Vecuronium—Cardiac disorder—Etoposide—hematologic cancer	0.000141	0.000872	CcSEcCtD
Vecuronium—Flushing—Etoposide—hematologic cancer	0.000141	0.000872	CcSEcCtD
Vecuronium—Rash—Procarbazine—hematologic cancer	0.00014	0.00087	CcSEcCtD
Vecuronium—Dermatitis—Procarbazine—hematologic cancer	0.00014	0.000869	CcSEcCtD
Vecuronium—Hypersensitivity—Vinblastine—hematologic cancer	0.000139	0.000863	CcSEcCtD
Vecuronium—Urticaria—Lenalidomide—hematologic cancer	0.000139	0.00086	CcSEcCtD
Vecuronium—Muscular weakness—Prednisone—hematologic cancer	0.000139	0.000859	CcSEcCtD
Vecuronium—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000138	0.000855	CcSEcCtD
Vecuronium—Rash—Bexarotene—hematologic cancer	0.000138	0.000853	CcSEcCtD
Vecuronium—Rash—Dasatinib—hematologic cancer	0.000138	0.000853	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—hematologic cancer	0.000138	0.000853	CcSEcCtD
Vecuronium—Dermatitis—Dasatinib—hematologic cancer	0.000137	0.000852	CcSEcCtD
Vecuronium—Dermatitis—Bexarotene—hematologic cancer	0.000137	0.000852	CcSEcCtD
Vecuronium—Rash—Fludarabine—hematologic cancer	0.000137	0.000851	CcSEcCtD
Vecuronium—Dermatitis—Fludarabine—hematologic cancer	0.000137	0.00085	CcSEcCtD
Vecuronium—Immune system disorder—Etoposide—hematologic cancer	0.000137	0.000849	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—hematologic cancer	0.000137	0.000847	CcSEcCtD
Vecuronium—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000136	0.000845	CcSEcCtD
Vecuronium—Tachycardia—Carmustine—hematologic cancer	0.000136	0.000843	CcSEcCtD
Vecuronium—Shock—Alitretinoin—hematologic cancer	0.000136	0.000841	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—hematologic cancer	0.000136	0.000841	CcSEcCtD
Vecuronium—Hypotension—Thalidomide—hematologic cancer	0.000136	0.00084	CcSEcCtD
Vecuronium—Nervous system disorder—Alitretinoin—hematologic cancer	0.000135	0.000839	CcSEcCtD
Vecuronium—Tachycardia—Alitretinoin—hematologic cancer	0.000135	0.000835	CcSEcCtD
Vecuronium—Skin disorder—Alitretinoin—hematologic cancer	0.000134	0.000831	CcSEcCtD
Vecuronium—Nervous system disorder—Ifosfamide—hematologic cancer	0.000134	0.000829	CcSEcCtD
Vecuronium—Anaphylactic shock—Vincristine—hematologic cancer	0.000133	0.000824	CcSEcCtD
Vecuronium—Skin disorder—Ifosfamide—hematologic cancer	0.000132	0.000821	CcSEcCtD
Vecuronium—Hypersensitivity—Melphalan—hematologic cancer	0.000132	0.000821	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.000131	0.00081	CcSEcCtD
Vecuronium—Nervous system disorder—Vincristine—hematologic cancer	0.00013	0.000808	CcSEcCtD
Vecuronium—Erythema—Prednisolone—hematologic cancer	0.00013	0.000807	CcSEcCtD
Vecuronium—Hypotension—Carmustine—hematologic cancer	0.00013	0.000807	CcSEcCtD
Vecuronium—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000129	0.000803	CcSEcCtD
Vecuronium—Anaphylactic shock—Irinotecan—hematologic cancer	0.000129	0.000803	CcSEcCtD
Vecuronium—Hypotension—Alitretinoin—hematologic cancer	0.000129	0.000799	CcSEcCtD
Vecuronium—Hypersensitivity—Lenalidomide—hematologic cancer	0.000129	0.000798	CcSEcCtD
Vecuronium—Urticaria—Bortezomib—hematologic cancer	0.000128	0.000792	CcSEcCtD
Vecuronium—Hypotension—Ifosfamide—hematologic cancer	0.000127	0.00079	CcSEcCtD
Vecuronium—Shock—Mitoxantrone—hematologic cancer	0.000127	0.00079	CcSEcCtD
Vecuronium—Shock—Irinotecan—hematologic cancer	0.000127	0.00079	CcSEcCtD
Vecuronium—Rash—Nilotinib—hematologic cancer	0.000127	0.000788	CcSEcCtD
Vecuronium—Dermatitis—Nilotinib—hematologic cancer	0.000127	0.000787	CcSEcCtD
Vecuronium—Nervous system disorder—Irinotecan—hematologic cancer	0.000127	0.000787	CcSEcCtD
Vecuronium—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000127	0.000787	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.000127	0.000787	CcSEcCtD
Vecuronium—Urticaria—Bleomycin—hematologic cancer	0.000127	0.000786	CcSEcCtD
Vecuronium—Rash—Imatinib—hematologic cancer	0.000126	0.000784	CcSEcCtD
Vecuronium—Tachycardia—Mitoxantrone—hematologic cancer	0.000126	0.000783	CcSEcCtD
Vecuronium—Dermatitis—Imatinib—hematologic cancer	0.000126	0.000783	CcSEcCtD
Vecuronium—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000126	0.000782	CcSEcCtD
Vecuronium—CHRNA2—blood—hematologic cancer	0.000126	0.121	CbGeAlD
Vecuronium—Skin disorder—Mitoxantrone—hematologic cancer	0.000126	0.00078	CcSEcCtD
Vecuronium—Urticaria—Vinorelbine—hematologic cancer	0.000125	0.000773	CcSEcCtD
Vecuronium—Hypotension—Vincristine—hematologic cancer	0.000124	0.00077	CcSEcCtD
Vecuronium—Rash—Cladribine—hematologic cancer	0.000124	0.00077	CcSEcCtD
Vecuronium—Dermatitis—Cladribine—hematologic cancer	0.000124	0.000769	CcSEcCtD
Vecuronium—Nervous system disorder—Gemcitabine—hematologic cancer	0.000124	0.000767	CcSEcCtD
Vecuronium—Skin disorder—Gemcitabine—hematologic cancer	0.000123	0.000759	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000122	0.000755	CcSEcCtD
Vecuronium—Hypotension—Mitoxantrone—hematologic cancer	0.000121	0.00075	CcSEcCtD
Vecuronium—Hypotension—Irinotecan—hematologic cancer	0.000121	0.00075	CcSEcCtD
Vecuronium—Erythema—Triamcinolone—hematologic cancer	0.00012	0.000742	CcSEcCtD
Vecuronium—Urticaria—Thiotepa—hematologic cancer	0.000119	0.000738	CcSEcCtD
Vecuronium—Angioedema—Prednisolone—hematologic cancer	0.000119	0.000737	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—hematologic cancer	0.000119	0.000735	CcSEcCtD
Vecuronium—Hypersensitivity—Bortezomib—hematologic cancer	0.000118	0.000734	CcSEcCtD
Vecuronium—Hypotension—Gemcitabine—hematologic cancer	0.000118	0.000731	CcSEcCtD
Vecuronium—Anaphylactic shock—Cisplatin—hematologic cancer	0.000118	0.000729	CcSEcCtD
Vecuronium—Hypersensitivity—Bleomycin—hematologic cancer	0.000118	0.000729	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.000117	0.000728	CcSEcCtD
Vecuronium—CHRNB1—blood—hematologic cancer	0.000117	0.113	CbGeAlD
Vecuronium—Hypersensitivity—Vinorelbine—hematologic cancer	0.000116	0.000717	CcSEcCtD
Vecuronium—Nervous system disorder—Cisplatin—hematologic cancer	0.000115	0.000715	CcSEcCtD
Vecuronium—Urticaria—Thalidomide—hematologic cancer	0.000115	0.000714	CcSEcCtD
Vecuronium—Tachycardia—Cisplatin—hematologic cancer	0.000115	0.000711	CcSEcCtD
Vecuronium—Skin disorder—Cisplatin—hematologic cancer	0.000114	0.000708	CcSEcCtD
Vecuronium—Rash—Melphalan—hematologic cancer	0.000113	0.000702	CcSEcCtD
Vecuronium—Dermatitis—Melphalan—hematologic cancer	0.000113	0.000702	CcSEcCtD
Vecuronium—Angiopathy—Betamethasone—hematologic cancer	0.000113	0.000702	CcSEcCtD
Vecuronium—Angiopathy—Dexamethasone—hematologic cancer	0.000113	0.000702	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000112	0.000692	CcSEcCtD
Vecuronium—Hypersensitivity—Thiotepa—hematologic cancer	0.00011	0.000685	CcSEcCtD
Vecuronium—Rash—Lenalidomide—hematologic cancer	0.00011	0.000683	CcSEcCtD
Vecuronium—Dermatitis—Lenalidomide—hematologic cancer	0.00011	0.000682	CcSEcCtD
Vecuronium—Hypotension—Cisplatin—hematologic cancer	0.00011	0.000681	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—hematologic cancer	0.00011	0.00068	CcSEcCtD
Vecuronium—Urticaria—Alitretinoin—hematologic cancer	0.00011	0.000679	CcSEcCtD
Vecuronium—Angioedema—Triamcinolone—hematologic cancer	0.000109	0.000678	CcSEcCtD
Vecuronium—Rash—Hydroxyurea—hematologic cancer	0.000109	0.000673	CcSEcCtD
Vecuronium—Erythema—Betamethasone—hematologic cancer	0.000109	0.000673	CcSEcCtD
Vecuronium—Erythema—Dexamethasone—hematologic cancer	0.000109	0.000673	CcSEcCtD
Vecuronium—Dermatitis—Hydroxyurea—hematologic cancer	0.000109	0.000673	CcSEcCtD
Vecuronium—Muscular weakness—Epirubicin—hematologic cancer	0.000108	0.000672	CcSEcCtD
Vecuronium—Urticaria—Ifosfamide—hematologic cancer	0.000108	0.000672	CcSEcCtD
Vecuronium—Anaphylactic shock—Etoposide—hematologic cancer	0.000108	0.000668	CcSEcCtD
Vecuronium—Hypersensitivity—Thalidomide—hematologic cancer	0.000107	0.000662	CcSEcCtD
Vecuronium—Connective tissue disorder—Prednisone—hematologic cancer	0.000107	0.000662	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisolone—hematologic cancer	0.000106	0.000658	CcSEcCtD
Vecuronium—Tachycardia—Etoposide—hematologic cancer	0.000105	0.000652	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—hematologic cancer	0.000105	0.000648	CcSEcCtD
Vecuronium—Shock—Prednisolone—hematologic cancer	0.000105	0.000648	CcSEcCtD
Vecuronium—Tachycardia—Prednisolone—hematologic cancer	0.000104	0.000643	CcSEcCtD
Vecuronium—Urticaria—Mitoxantrone—hematologic cancer	0.000103	0.000638	CcSEcCtD
Vecuronium—Hypersensitivity—Carmustine—hematologic cancer	0.000103	0.000636	CcSEcCtD
Vecuronium—Hypersensitivity—Alitretinoin—hematologic cancer	0.000102	0.00063	CcSEcCtD
Vecuronium—Rash—Bortezomib—hematologic cancer	0.000101	0.000628	CcSEcCtD
Vecuronium—Dermatitis—Bortezomib—hematologic cancer	0.000101	0.000628	CcSEcCtD
Vecuronium—Flushing—Prednisone—hematologic cancer	0.000101	0.000625	CcSEcCtD
Vecuronium—Hypotension—Etoposide—hematologic cancer	0.000101	0.000624	CcSEcCtD
Vecuronium—Rash—Bleomycin—hematologic cancer	0.000101	0.000624	CcSEcCtD
Vecuronium—Dermatitis—Bleomycin—hematologic cancer	0.000101	0.000623	CcSEcCtD
Vecuronium—Hypersensitivity—Ifosfamide—hematologic cancer	0.0001	0.000623	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—hematologic cancer	0.0001	0.000621	CcSEcCtD
Vecuronium—Angioedema—Betamethasone—hematologic cancer	9.92e-05	0.000615	CcSEcCtD
Vecuronium—Angioedema—Dexamethasone—hematologic cancer	9.92e-05	0.000615	CcSEcCtD
Vecuronium—Rash—Vinorelbine—hematologic cancer	9.9e-05	0.000614	CcSEcCtD
Vecuronium—Dermatitis—Vinorelbine—hematologic cancer	9.89e-05	0.000613	CcSEcCtD
Vecuronium—Angiopathy—Prednisone—hematologic cancer	9.86e-05	0.000611	CcSEcCtD
Vecuronium—Immune system disorder—Prednisone—hematologic cancer	9.81e-05	0.000608	CcSEcCtD
Vecuronium—Hypersensitivity—Vincristine—hematologic cancer	9.8e-05	0.000607	CcSEcCtD
Vecuronium—Anaphylactic shock—Triamcinolone—hematologic cancer	9.77e-05	0.000606	CcSEcCtD
Vecuronium—CHRNB1—testis—hematologic cancer	9.7e-05	0.0934	CbGeAlD
Vecuronium—Shock—Triamcinolone—hematologic cancer	9.61e-05	0.000596	CcSEcCtD
Vecuronium—Hypersensitivity—Irinotecan—hematologic cancer	9.54e-05	0.000591	CcSEcCtD
Vecuronium—Hypersensitivity—Mitoxantrone—hematologic cancer	9.54e-05	0.000591	CcSEcCtD
Vecuronium—Tachycardia—Triamcinolone—hematologic cancer	9.53e-05	0.000591	CcSEcCtD
Vecuronium—Erythema—Prednisone—hematologic cancer	9.46e-05	0.000586	CcSEcCtD
Vecuronium—Rash—Thiotepa—hematologic cancer	9.45e-05	0.000586	CcSEcCtD
Vecuronium—Dermatitis—Thiotepa—hematologic cancer	9.45e-05	0.000585	CcSEcCtD
Vecuronium—Rash—Thalidomide—hematologic cancer	9.14e-05	0.000567	CcSEcCtD
Vecuronium—Dermatitis—Thalidomide—hematologic cancer	9.14e-05	0.000566	CcSEcCtD
Vecuronium—Anaphylactic shock—Dexamethasone—hematologic cancer	8.86e-05	0.000549	CcSEcCtD
Vecuronium—Anaphylactic shock—Betamethasone—hematologic cancer	8.86e-05	0.000549	CcSEcCtD
Vecuronium—Rash—Carmustine—hematologic cancer	8.78e-05	0.000544	CcSEcCtD
Vecuronium—Dermatitis—Carmustine—hematologic cancer	8.77e-05	0.000544	CcSEcCtD
Vecuronium—Shock—Betamethasone—hematologic cancer	8.72e-05	0.000541	CcSEcCtD
Vecuronium—Shock—Dexamethasone—hematologic cancer	8.72e-05	0.000541	CcSEcCtD
Vecuronium—Rash—Alitretinoin—hematologic cancer	8.7e-05	0.000539	CcSEcCtD
Vecuronium—Nervous system disorder—Dexamethasone—hematologic cancer	8.69e-05	0.000539	CcSEcCtD
Vecuronium—Nervous system disorder—Betamethasone—hematologic cancer	8.69e-05	0.000539	CcSEcCtD
Vecuronium—Dermatitis—Alitretinoin—hematologic cancer	8.69e-05	0.000539	CcSEcCtD
Vecuronium—Hypersensitivity—Cisplatin—hematologic cancer	8.66e-05	0.000537	CcSEcCtD
Vecuronium—Tachycardia—Dexamethasone—hematologic cancer	8.65e-05	0.000536	CcSEcCtD
Vecuronium—Tachycardia—Betamethasone—hematologic cancer	8.65e-05	0.000536	CcSEcCtD
Vecuronium—Angioedema—Prednisone—hematologic cancer	8.64e-05	0.000536	CcSEcCtD
Vecuronium—Rash—Ifosfamide—hematologic cancer	8.6e-05	0.000533	CcSEcCtD
Vecuronium—Dermatitis—Ifosfamide—hematologic cancer	8.59e-05	0.000532	CcSEcCtD
Vecuronium—Urticaria—Etoposide—hematologic cancer	8.56e-05	0.00053	CcSEcCtD
Vecuronium—Urticaria—Prednisolone—hematologic cancer	8.44e-05	0.000523	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—hematologic cancer	8.43e-05	0.000522	CcSEcCtD
Vecuronium—Rash—Vincristine—hematologic cancer	8.38e-05	0.00052	CcSEcCtD
Vecuronium—Dermatitis—Vincristine—hematologic cancer	8.38e-05	0.000519	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—hematologic cancer	8.35e-05	0.000518	CcSEcCtD
Vecuronium—Hypotension—Betamethasone—hematologic cancer	8.28e-05	0.000513	CcSEcCtD
Vecuronium—Hypotension—Dexamethasone—hematologic cancer	8.28e-05	0.000513	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—hematologic cancer	8.24e-05	0.000511	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—hematologic cancer	8.2e-05	0.000508	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—hematologic cancer	8.18e-05	0.000507	CcSEcCtD
Vecuronium—Rash—Mitoxantrone—hematologic cancer	8.16e-05	0.000506	CcSEcCtD
Vecuronium—Rash—Irinotecan—hematologic cancer	8.16e-05	0.000506	CcSEcCtD
Vecuronium—Dermatitis—Mitoxantrone—hematologic cancer	8.16e-05	0.000506	CcSEcCtD
Vecuronium—Dermatitis—Irinotecan—hematologic cancer	8.16e-05	0.000506	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8e-05	0.000496	CcSEcCtD
Vecuronium—Rash—Gemcitabine—hematologic cancer	7.95e-05	0.000493	CcSEcCtD
Vecuronium—Dermatitis—Gemcitabine—hematologic cancer	7.95e-05	0.000492	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—hematologic cancer	7.94e-05	0.000492	CcSEcCtD
Vecuronium—Erythema—Methotrexate—hematologic cancer	7.91e-05	0.00049	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—hematologic cancer	7.89e-05	0.000489	CcSEcCtD
Vecuronium—Flushing—Epirubicin—hematologic cancer	7.89e-05	0.000489	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisolone—hematologic cancer	7.83e-05	0.000485	CcSEcCtD
Vecuronium—Urticaria—Triamcinolone—hematologic cancer	7.76e-05	0.000481	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—hematologic cancer	7.73e-05	0.000479	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisone—hematologic cancer	7.72e-05	0.000478	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—hematologic cancer	7.71e-05	0.000478	CcSEcCtD
Vecuronium—Immune system disorder—Epirubicin—hematologic cancer	7.68e-05	0.000476	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—hematologic cancer	7.66e-05	0.000475	CcSEcCtD
Vecuronium—Shock—Prednisone—hematologic cancer	7.59e-05	0.000471	CcSEcCtD
Vecuronium—Nervous system disorder—Prednisone—hematologic cancer	7.57e-05	0.000469	CcSEcCtD
Vecuronium—Tachycardia—Prednisone—hematologic cancer	7.53e-05	0.000467	CcSEcCtD
Vecuronium—Skin disorder—Prednisone—hematologic cancer	7.5e-05	0.000465	CcSEcCtD
Vecuronium—Rash—Cisplatin—hematologic cancer	7.41e-05	0.000459	CcSEcCtD
Vecuronium—Dermatitis—Cisplatin—hematologic cancer	7.41e-05	0.000459	CcSEcCtD
Vecuronium—Erythema—Epirubicin—hematologic cancer	7.4e-05	0.000459	CcSEcCtD
Vecuronium—SLC22A1—blood—hematologic cancer	7.38e-05	0.0711	CbGeAlD
Vecuronium—Cardiac disorder—Doxorubicin—hematologic cancer	7.3e-05	0.000452	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—hematologic cancer	7.3e-05	0.000452	CcSEcCtD
Vecuronium—Hypersensitivity—Triamcinolone—hematologic cancer	7.2e-05	0.000446	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—hematologic cancer	7.13e-05	0.000442	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—hematologic cancer	7.1e-05	0.00044	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—hematologic cancer	7.09e-05	0.000439	CcSEcCtD
Vecuronium—Urticaria—Betamethasone—hematologic cancer	7.04e-05	0.000436	CcSEcCtD
Vecuronium—Urticaria—Dexamethasone—hematologic cancer	7.04e-05	0.000436	CcSEcCtD
Vecuronium—CHRNB1—lymph node—hematologic cancer	7.03e-05	0.0677	CbGeAlD
Vecuronium—Erythema—Doxorubicin—hematologic cancer	6.85e-05	0.000424	CcSEcCtD
Vecuronium—Rash—Etoposide—hematologic cancer	6.79e-05	0.000421	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—hematologic cancer	6.78e-05	0.000421	CcSEcCtD
Vecuronium—Rash—Prednisolone—hematologic cancer	6.7e-05	0.000415	CcSEcCtD
Vecuronium—Dermatitis—Prednisolone—hematologic cancer	6.69e-05	0.000415	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.68e-05	0.000414	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—hematologic cancer	6.45e-05	0.0004	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—hematologic cancer	6.33e-05	0.000392	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—hematologic cancer	6.27e-05	0.000388	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.25e-05	0.000388	CcSEcCtD
Vecuronium—Rash—Triamcinolone—hematologic cancer	6.16e-05	0.000382	CcSEcCtD
Vecuronium—Dermatitis—Triamcinolone—hematologic cancer	6.15e-05	0.000381	CcSEcCtD
Vecuronium—Urticaria—Prednisone—hematologic cancer	6.13e-05	0.00038	CcSEcCtD
Vecuronium—Anaphylactic shock—Epirubicin—hematologic cancer	6.04e-05	0.000374	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—hematologic cancer	6.03e-05	0.000374	CcSEcCtD
Vecuronium—Shock—Epirubicin—hematologic cancer	5.94e-05	0.000368	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—hematologic cancer	5.92e-05	0.000367	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—hematologic cancer	5.89e-05	0.000365	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—hematologic cancer	5.86e-05	0.000363	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.79e-05	0.000359	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisone—hematologic cancer	5.69e-05	0.000353	CcSEcCtD
Vecuronium—Hypotension—Epirubicin—hematologic cancer	5.64e-05	0.00035	CcSEcCtD
Vecuronium—Rash—Betamethasone—hematologic cancer	5.59e-05	0.000346	CcSEcCtD
Vecuronium—Rash—Dexamethasone—hematologic cancer	5.59e-05	0.000346	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—hematologic cancer	5.59e-05	0.000346	CcSEcCtD
Vecuronium—Dermatitis—Dexamethasone—hematologic cancer	5.58e-05	0.000346	CcSEcCtD
Vecuronium—Dermatitis—Betamethasone—hematologic cancer	5.58e-05	0.000346	CcSEcCtD
Vecuronium—Shock—Doxorubicin—hematologic cancer	5.5e-05	0.000341	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—hematologic cancer	5.48e-05	0.00034	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—hematologic cancer	5.45e-05	0.000338	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—hematologic cancer	5.43e-05	0.000336	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—hematologic cancer	5.22e-05	0.000324	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—hematologic cancer	5.13e-05	0.000318	CcSEcCtD
Vecuronium—Rash—Prednisone—hematologic cancer	4.87e-05	0.000302	CcSEcCtD
Vecuronium—Dermatitis—Prednisone—hematologic cancer	4.86e-05	0.000301	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—hematologic cancer	4.8e-05	0.000297	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—hematologic cancer	4.75e-05	0.000295	CcSEcCtD
Vecuronium—Hypersensitivity—Epirubicin—hematologic cancer	4.45e-05	0.000276	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—hematologic cancer	4.44e-05	0.000275	CcSEcCtD
Vecuronium—Hypersensitivity—Doxorubicin—hematologic cancer	4.12e-05	0.000255	CcSEcCtD
Vecuronium—Rash—Methotrexate—hematologic cancer	4.07e-05	0.000252	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—hematologic cancer	4.06e-05	0.000252	CcSEcCtD
Vecuronium—Rash—Epirubicin—hematologic cancer	3.81e-05	0.000236	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—hematologic cancer	3.8e-05	0.000236	CcSEcCtD
Vecuronium—ABCB1—hematopoietic system—hematologic cancer	3.59e-05	0.0346	CbGeAlD
Vecuronium—Rash—Doxorubicin—hematologic cancer	3.52e-05	0.000218	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—hematologic cancer	3.52e-05	0.000218	CcSEcCtD
Vecuronium—ABCB1—gonad—hematologic cancer	2.73e-05	0.0263	CbGeAlD
Vecuronium—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	2.45e-05	0.00162	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—CREB1—hematologic cancer	2.45e-05	0.00162	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	2.43e-05	0.00161	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—BRAF—hematologic cancer	2.42e-05	0.0016	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	2.4e-05	0.00159	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—CAMK2D—hematologic cancer	2.4e-05	0.00159	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.39e-05	0.00159	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.39e-05	0.00158	CbGpPWpGaD
Vecuronium—ABCB1—blood—hematologic cancer	2.38e-05	0.0229	CbGeAlD
Vecuronium—ABCB1—Allograft Rejection—FASLG—hematologic cancer	2.38e-05	0.00158	CbGpPWpGaD
Vecuronium—ABCB1—bone marrow—hematologic cancer	2.3e-05	0.0222	CbGeAlD
Vecuronium—ABCB1—Allograft Rejection—FAS—hematologic cancer	2.29e-05	0.00152	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	2.28e-05	0.00151	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	2.28e-05	0.00151	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	2.25e-05	0.00149	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	2.23e-05	0.00148	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.19e-05	0.00145	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.19e-05	0.00145	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.19e-05	0.00145	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	2.16e-05	0.00143	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—MDM2—hematologic cancer	2.13e-05	0.00141	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	2.09e-05	0.00139	CbGpPWpGaD
Vecuronium—ABCB1—lung—hematologic cancer	2.09e-05	0.0201	CbGeAlD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	2.09e-05	0.00138	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	2.08e-05	0.00138	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	2.03e-05	0.00135	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.03e-05	0.00135	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	2.03e-05	0.00135	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—MDM2—hematologic cancer	2.02e-05	0.00134	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	2e-05	0.00133	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	1.98e-05	0.00131	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.97e-05	0.00131	CbGpPWpGaD
Vecuronium—ABCB1—testis—hematologic cancer	1.97e-05	0.019	CbGeAlD
Vecuronium—SLC22A1—Metabolism—FTCD—hematologic cancer	1.95e-05	0.00129	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PHYH—hematologic cancer	1.95e-05	0.00129	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GMPS—hematologic cancer	1.95e-05	0.00129	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	1.93e-05	0.00128	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CD80—hematologic cancer	1.9e-05	0.00126	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	1.86e-05	0.00123	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	1.85e-05	0.00122	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.79e-05	0.00119	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SMPD3—hematologic cancer	1.79e-05	0.00118	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP8—hematologic cancer	1.77e-05	0.00117	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	1.76e-05	0.00117	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.73e-05	0.00115	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	1.69e-05	0.00112	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	1.61e-05	0.00106	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	1.57e-05	0.00104	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—B3GAT1—hematologic cancer	1.56e-05	0.00103	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—DCK—hematologic cancer	1.56e-05	0.00103	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ASNS—hematologic cancer	1.56e-05	0.00103	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	1.53e-05	0.00101	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.53e-05	0.00101	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—PRKCG—hematologic cancer	1.52e-05	0.00101	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IFNG—hematologic cancer	1.5e-05	0.000997	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	1.5e-05	0.000995	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.49e-05	0.00099	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	1.49e-05	0.000989	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	1.48e-05	0.000981	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HDC—hematologic cancer	1.48e-05	0.000981	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—CREB1—hematologic cancer	1.47e-05	0.000972	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.45e-05	0.000961	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.45e-05	0.000961	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—BRAF—hematologic cancer	1.45e-05	0.00096	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	1.44e-05	0.000957	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.44e-05	0.000955	CbGpPWpGaD
Vecuronium—ABCB1—lymph node—hematologic cancer	1.43e-05	0.0138	CbGeAlD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.41e-05	0.000935	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	1.4e-05	0.00093	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	1.4e-05	0.000926	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	1.39e-05	0.000923	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	1.38e-05	0.000918	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—HRAS—hematologic cancer	1.38e-05	0.000911	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CDA—hematologic cancer	1.35e-05	0.000897	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	1.34e-05	0.00089	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	1.34e-05	0.00089	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL1B—hematologic cancer	1.34e-05	0.000889	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP3—hematologic cancer	1.34e-05	0.000887	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL2—hematologic cancer	1.34e-05	0.000886	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	1.33e-05	0.000882	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	1.31e-05	0.000869	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PC—hematologic cancer	1.3e-05	0.000863	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.28e-05	0.000851	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.28e-05	0.000851	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.28e-05	0.000851	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC35B2—hematologic cancer	1.26e-05	0.000834	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GBA—hematologic cancer	1.26e-05	0.000834	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.26e-05	0.000834	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.25e-05	0.000827	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.23e-05	0.000815	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	1.21e-05	0.000804	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.21e-05	0.000801	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.17e-05	0.000778	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—HRAS—hematologic cancer	1.17e-05	0.000775	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.16e-05	0.000766	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTAP—hematologic cancer	1.15e-05	0.000763	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PHYH—hematologic cancer	1.14e-05	0.000758	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GMPS—hematologic cancer	1.14e-05	0.000758	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—FTCD—hematologic cancer	1.14e-05	0.000758	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	1.14e-05	0.000753	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.13e-05	0.00075	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—CREB1—hematologic cancer	1.12e-05	0.000745	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—HRAS—hematologic cancer	1.11e-05	0.000736	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—BRAF—hematologic cancer	1.11e-05	0.000736	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.08e-05	0.000718	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.06e-05	0.000699	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.05e-05	0.000698	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SMPD3—hematologic cancer	1.05e-05	0.000694	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.04e-05	0.000691	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—FHL2—hematologic cancer	1.03e-05	0.00068	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.01e-05	0.000672	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.01e-05	0.00067	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AGRN—hematologic cancer	1.01e-05	0.000667	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1e-05	0.000663	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	9.95e-06	0.00066	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	9.91e-06	0.000657	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TNF—hematologic cancer	9.73e-06	0.000645	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	9.68e-06	0.000641	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	9.68e-06	0.000641	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—IDH2—hematologic cancer	9.53e-06	0.000632	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HMMR—hematologic cancer	9.53e-06	0.000632	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MDM2—hematologic cancer	9.3e-06	0.000616	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	9.28e-06	0.000615	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ASNS—hematologic cancer	9.15e-06	0.000606	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—B3GAT1—hematologic cancer	9.15e-06	0.000606	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—DCK—hematologic cancer	9.15e-06	0.000606	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ARNTL—hematologic cancer	8.96e-06	0.000594	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	8.92e-06	0.000591	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.81e-06	0.000584	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	8.76e-06	0.00058	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	8.73e-06	0.000578	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CA9—hematologic cancer	8.72e-06	0.000578	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ACP5—hematologic cancer	8.72e-06	0.000578	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	8.69e-06	0.000576	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HDC—hematologic cancer	8.67e-06	0.000575	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOR2—hematologic cancer	8.61e-06	0.00057	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	8.5e-06	0.000563	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	8.44e-06	0.000559	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	8.37e-06	0.000555	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	8.29e-06	0.00055	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	8.27e-06	0.000548	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—IDH1—hematologic cancer	8.2e-06	0.000543	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCC3—hematologic cancer	8.11e-06	0.000537	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TXN—hematologic cancer	8.11e-06	0.000537	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTO1—hematologic cancer	8.11e-06	0.000537	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SPHK1—hematologic cancer	7.93e-06	0.000526	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CDA—hematologic cancer	7.93e-06	0.000526	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	7.89e-06	0.000523	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PC—hematologic cancer	7.63e-06	0.000506	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UGT1A1—hematologic cancer	7.62e-06	0.000505	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	7.49e-06	0.000496	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CRABP1—hematologic cancer	7.41e-06	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	7.38e-06	0.000489	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GBA—hematologic cancer	7.37e-06	0.000489	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC35B2—hematologic cancer	7.37e-06	0.000489	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	7.37e-06	0.000489	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALOX5—hematologic cancer	7.23e-06	0.000479	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NUP98—hematologic cancer	7e-06	0.000464	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA3—hematologic cancer	6.79e-06	0.00045	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ADCY7—hematologic cancer	6.79e-06	0.00045	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NUP214—hematologic cancer	6.75e-06	0.000447	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTAP—hematologic cancer	6.74e-06	0.000447	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.74e-06	0.000447	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.66e-06	0.000441	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTR—hematologic cancer	6.61e-06	0.000438	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCG2—hematologic cancer	6.61e-06	0.000438	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	6.6e-06	0.000438	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ENO2—hematologic cancer	6.48e-06	0.00043	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	6.43e-06	0.000426	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	6.41e-06	0.000425	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTT1—hematologic cancer	6.29e-06	0.000417	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	6.22e-06	0.000412	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	6.2e-06	0.000411	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.19e-06	0.00041	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SDC1—hematologic cancer	6.14e-06	0.000407	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	6.07e-06	0.000402	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—FHL2—hematologic cancer	6.01e-06	0.000398	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.92e-06	0.000392	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AGRN—hematologic cancer	5.89e-06	0.000391	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.89e-06	0.00039	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.75e-06	0.000381	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.6e-06	0.000371	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HMMR—hematologic cancer	5.59e-06	0.00037	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—IDH2—hematologic cancer	5.59e-06	0.00037	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.51e-06	0.000365	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.3e-06	0.000351	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ARNTL—hematologic cancer	5.25e-06	0.000348	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NQO1—hematologic cancer	5.22e-06	0.000346	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CD44—hematologic cancer	5.22e-06	0.000346	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	5.16e-06	0.000342	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	5.14e-06	0.000341	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CA9—hematologic cancer	5.11e-06	0.000339	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ACP5—hematologic cancer	5.11e-06	0.000339	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—HRAS—hematologic cancer	5.1e-06	0.000338	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOR2—hematologic cancer	5.04e-06	0.000334	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYCS—hematologic cancer	4.94e-06	0.000328	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	4.91e-06	0.000326	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—IDH1—hematologic cancer	4.81e-06	0.000318	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.8e-06	0.000318	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.76e-06	0.000316	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCC3—hematologic cancer	4.75e-06	0.000315	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTO1—hematologic cancer	4.75e-06	0.000315	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TXN—hematologic cancer	4.75e-06	0.000315	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SPHK1—hematologic cancer	4.65e-06	0.000308	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.47e-06	0.000296	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.38e-06	0.00029	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTP1—hematologic cancer	4.36e-06	0.000289	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.35e-06	0.000288	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CRABP1—hematologic cancer	4.35e-06	0.000288	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALOX5—hematologic cancer	4.24e-06	0.000281	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.23e-06	0.000281	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCB1—hematologic cancer	4.12e-06	0.000273	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NUP98—hematologic cancer	4.1e-06	0.000272	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOR1—hematologic cancer	4e-06	0.000265	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM1—hematologic cancer	4e-06	0.000265	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ADCY7—hematologic cancer	3.98e-06	0.000264	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA3—hematologic cancer	3.98e-06	0.000264	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NUP214—hematologic cancer	3.95e-06	0.000262	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCG2—hematologic cancer	3.87e-06	0.000257	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTR—hematologic cancer	3.87e-06	0.000257	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ENO2—hematologic cancer	3.8e-06	0.000252	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTT1—hematologic cancer	3.68e-06	0.000244	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SDC1—hematologic cancer	3.6e-06	0.000239	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.58e-06	0.000237	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTHFR—hematologic cancer	3.54e-06	0.000235	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.45e-06	0.000229	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.23e-06	0.000214	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CD44—hematologic cancer	3.06e-06	0.000203	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NQO1—hematologic cancer	3.06e-06	0.000203	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.97e-06	0.000197	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYCS—hematologic cancer	2.9e-06	0.000192	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.88e-06	0.000191	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.76e-06	0.000183	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.61e-06	0.000173	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALB—hematologic cancer	2.58e-06	0.000171	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTP1—hematologic cancer	2.55e-06	0.000169	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.47e-06	0.000164	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM1—hematologic cancer	2.35e-06	0.000156	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOR1—hematologic cancer	2.35e-06	0.000156	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.28e-06	0.000151	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTHFR—hematologic cancer	2.07e-06	0.000137	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTEN—hematologic cancer	1.97e-06	0.00013	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—EP300—hematologic cancer	1.88e-06	0.000124	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.74e-06	0.000115	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CREBBP—hematologic cancer	1.62e-06	0.000107	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.53e-06	0.000102	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALB—hematologic cancer	1.51e-06	0.0001	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.45e-06	9.59e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.39e-06	9.2e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.34e-06	8.85e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTEN—hematologic cancer	1.15e-06	7.65e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKT1—hematologic cancer	1.13e-06	7.52e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—EP300—hematologic cancer	1.1e-06	7.29e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.14e-07	5.39e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKT1—hematologic cancer	6.65e-07	4.41e-05	CbGpPWpGaD
